◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

MediPharm Labs Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 11.4M 11.8M 10.8M 12.0M 9.8M --
Operating Revenue 12.2M 12.6M 11.5M 12.8M 10.6M --
Cost Of Revenue 8.9M 8.5M 6.6M 8.4M 6.7M --
Gross Profit 2.6M 3.3M 4.2M 3.6M 3.1M --
Selling General And Administration 4.5M 7.2M 4.7M 5.0M 5.5M --
General And Administrative Expense 3.4M 5.8M 3.5M 6.1M 4.1M --
Research And Development 47,000 46,000 78,000 35,000 126,000 --
Other Operating Expenses 189,000 -78,000 -184,000 -158,000 226,000 --
Operating Expense 4.8M 7.1M 4.6M 5.2M 5.8M --
Operating Income -2.2M -3.8M -441,000 -1.6M -2.7M --
EBIT -2.1M -3.8M -371,000 -1.7M -2.5M --
Interest Expense 16,000 12,000 16,000 21,000 235,000 --
Interest Expense Non Operating 16,000 12,000 16,000 21,000 235,000 --
Interest Income 62,000 42,000 70,000 98,000 169,000 --
Interest Income Non Operating 62,000 42,000 70,000 98,000 169,000 --
Net Interest Income 46,000 30,000 54,000 77,000 -66,000 --
Special Income Charges -- -- -- -296,000 0.00 0.00
Restructuring And Mergern Acquisition -- -- -- 0.00 0.00 0.00
Pretax Income -2.1M -3.8M -387,000 -1.7M -2.8M --
Tax Provision -- -- -- 0.00 0.00 --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -2.1M -3.8M -387,000 -1.7M -2.8M --
Net Income From Continuing Operation Net Minority Interest -2.1M -3.8M -387,000 -1.7M -2.8M --
Net Income Including Noncontrolling Interests -2.1M -3.8M -387,000 -1.7M -2.8M --
Net Income Common Stockholders -2.1M -3.8M -387,000 -1.7M -2.8M --
Net Income -2.1M -3.8M -387,000 -1.7M -2.8M --
EBITDA -1.7M -3.3M 54,000 -1.1M -2.0M --
Normalized EBITDA -1.7M -3.3M 54,000 -903,000 -2.0M --
Reconciled Depreciation 420,000 419,000 425,000 561,000 518,000 --
Basic EPS -0.01 -0.01 -0.00 -- -0.01 -0.01
Diluted EPS -0.01 -0.01 -0.00 -- -0.01 -0.01
Basic Average Shares 420.8M 415.4M 415.1M -- 411.1M 404.8M
Diluted Average Shares 420.8M 415.4M 415.1M -- 411.1M 404.8M
Total Unusual Items -- -- -- -241,000 0.00 0.00
Total Unusual Items Excluding Goodwill -- -- -- -241,000 0.00 0.00
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00 --
Normalized Income -2.1M -3.8M -387,000 -1.5M -2.8M --
Diluted NI Availto Com Stockholders -2.1M -3.8M -387,000 -1.7M -2.8M --
Excise Taxes 770,000 804,000 723,000 757,000 799,000 --
Net Income Continuous Operations -2.1M -3.8M -387,000 -1.7M -2.8M --
Net Non Operating Interest Income Expense 46,000 30,000 54,000 77,000 -66,000 --
Other Gand A 3.2M 5.3M 3.0M -5.5M 3.9M --
Reconciled Cost Of Revenue 8.9M 8.5M 6.6M 8.4M 6.7M --
Rent Expense Supplemental -- 267,000 413,000 -- -- 323,000
Salaries And Wages 194,000 502,000 437,000 10.6M 160,000 --
Selling And Marketing Expense 1.2M 1.4M 1.2M -1.1M 1.4M --
Total Expenses 13.6M 15.6M 11.2M 13.6M 12.5M --
Total Operating Income As Reported -2.2M -3.8M -441,000 -1.8M -2.7M --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 10.6M 10.4M 8.4M 11.7M 13.1M --
Cash Cash Equivalents And Short Term Investments 10.6M 10.4M 8.4M 11.7M 13.1M --
Accounts Receivable 6.6M 7.0M 7.4M 6.9M 6.2M --
Receivables 7.7M 8.0M 7.8M 7.5M 6.7M --
Inventory 8.1M 9.3M 10.6M 8.7M 9.2M --
Prepaid Assets 1.2M 1.0M 356,000 609,000 1.0M --
Other Current Assets 288,000 299,000 268,000 213,000 233,000 --
Current Assets 27.9M 29.5M 31.8M 33.1M 34.6M --
Gross PPE 41.9M 42.6M 42.5M 42.5M 42.4M --
Accumulated Depreciation -24.0M -24.1M -23.7M -23.3M -22.7M --
Net PPE 17.9M 18.5M 18.8M 19.2M 19.6M --
Goodwill And Other Intangible Assets 720,000 764,000 809,000 854,000 898,000 --
Other Intangible Assets 720,000 764,000 809,000 854,000 898,000 --
Total Non Current Assets 18.7M 19.8M 20.3M 20.6M 21.3M --
Total Assets 46.6M 49.3M 52.1M 53.7M 55.8M --
Current Debt 351,000 450,000 14,000 258,000 571,000 --
Current Debt And Capital Lease Obligation 423,000 532,000 94,000 337,000 619,000 --
Accounts Payable 4.7M 4.6M 4.9M 4.2M 3.5M --
Payables 5.5M 5.6M 6.0M 5.1M 4.2M --
Payables And Accrued Expenses 7.3M 7.4M 7.9M 6.8M 6.9M --
Current Accrued Expenses 1.8M 1.8M 2.0M 1.7M 2.8M --
Current Deferred Revenue 530,000 497,000 568,000 607,000 843,000 --
Current Liabilities 8.7M 9.5M 8.8M 10.5M 10.8M --
Long Term Debt And Capital Lease Obligation 0.00 10,000 31,000 51,000 35,000 --
Long Term Capital Lease Obligation 0.00 10,000 31,000 51,000 35,000 --
Total Non Current Liabilities Net Minority Interest 0.00 10,000 31,000 51,000 35,000 --
Total Liabilities Net Minority Interest 8.7M 9.5M 8.8M 10.5M 10.8M --
Common Stock 201.6M 201.6M 201.2M 201.2M 201.0M --
Capital Stock 201.6M 201.6M 201.2M 201.2M 201.0M --
Retained Earnings -188.6M -186.5M -187.8M -187.4M -185.7M --
Gains Losses Not Affecting Retained Earnings -98,000 24.7M 29.8M 29.4M 29.8M --
Other Equity Adjustments -98,000 24.7M 29.8M 29.4M 29.8M --
Common Stock Equity 37.9M 39.8M 43.2M 43.2M 45.0M --
Stockholders Equity 37.9M 39.8M 43.2M 43.2M 45.0M --
Total Equity Gross Minority Interest 37.9M 39.8M 43.2M 43.2M 45.0M --
Total Capitalization 37.9M 39.8M 43.2M 43.2M 45.0M --
Net Tangible Assets 37.1M 39.1M 42.4M 42.3M 44.2M --
Tangible Book Value 37.1M 39.1M 42.4M 42.3M 44.2M --
Working Capital 19.2M 20.0M 23.0M 22.6M 23.8M --
Invested Capital 38.2M 40.3M 43.2M 43.4M 45.6M --
Total Debt 423,000 542,000 125,000 388,000 654,000 --
Share Issued 420.8M 420.8M 415.1M 415.0M 411.1M --
Ordinary Shares Number 420.8M 420.8M 415.1M 415.0M 411.1M --
Allowance For Doubtful Accounts Receivable -20,000 -15,000 -- -78,000 -- --
Assets Held For Sale Current 0.00 474,000 4.3M 4.3M 4.3M --
Buildings And Improvements 25.3M 25.3M 25.0M 25.3M 25.2M --
Capital Lease Obligations 72,000 92,000 111,000 130,000 83,000 --
Construction In Progress 10,000 0.00 0.00 45,000 1,000 --
Current Capital Lease Obligation 72,000 82,000 80,000 79,000 48,000 --
Current Deferred Liabilities 530,000 497,000 568,000 607,000 843,000 --
Finished Goods 4.7M 5.1M 6.3M 5.9M 5.0M --
Gross Accounts Receivable 6.6M 7.1M -- 7.0M -- --
Land And Improvements 1.9M 1.9M 1.9M 1.9M 1.9M --
Leases 209,000 209,000 209,000 209,000 209,000 --
Machinery Furniture Equipment 13.8M 14.5M 14.5M 14.4M 14.4M --
Non Current Prepaid Assets 0.00 539,000 635,000 635,000 748,000 --
Other Current Borrowings 351,000 450,000 14,000 258,000 571,000 --
Other Equity Interest 25.0M -- -- -- -- --
Other Inventories 172,000 221,000 172,000 147,000 148,000 --
Other Payable 755,000 1.0M 1.1M 826,000 656,000 --
Other Properties 738,000 738,000 1.0M 738,000 738,000 --
Other Receivables 106,000 283,000 20,000 32,000 59,000 --
Pensionand Other Post Retirement Benefit Plans Current 521,000 1.1M 217,000 2.8M 2.4M --
Properties 0.00 0.00 0.00 0.00 0.00 --
Raw Materials 3.3M 4.0M 4.1M 2.6M 4.0M --
Taxes Receivable 997,000 690,000 366,000 602,000 406,000 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -158,000 -2.8M -3.0M -1.1M -662,000 --
Cash Flow From Continuing Operating Activities -158,000 -2.8M -3.0M -1.1M -662,000 --
Depreciation And Amortization 420,000 419,000 425,000 561,000 518,000 --
Depreciation Amortization Depletion 420,000 419,000 425,000 561,000 518,000 --
Stock Based Compensation 194,000 502,000 437,000 -655,000 160,000 --
Change In Working Capital 1.4M 272,000 -3.4M 821,000 878,000 --
Changes In Account Receivables -- -- -281,000 -793,000 -473,000 319,000
Change In Receivables 286,000 -230,000 -281,000 -793,000 -473,000 --
Change In Inventory 1.4M 1.3M -1.9M 621,000 164,000 --
Change In Payables And Accrued Expense 32,000 -512,000 635,000 31,000 553,000 --
Change In Payable 32,000 -512,000 635,000 31,000 553,000 --
Change In Other Working Capital -643,000 356,000 -2.1M 543,000 200,000 --
Change In Other Current Assets 308,000 -595,000 198,000 419,000 434,000 --
Other Non Cash Items -185,000 -123,000 -100,000 -130,000 585,000 --
Capital Expenditure -16,000 -42,000 -42,000 -44,000 -33,000 --
Net PPE Purchase And Sale 35,000 0.00 0.00 0.00 0.00 --
Sale Of Business -- -- -- 0.00 0.00 --
Investing Cash Flow 459,000 4.2M -42,000 -44,000 -33,000 --
Cash Flow From Continuing Investing Activities 459,000 4.2M -42,000 -44,000 -33,000 --
Issuance Of Debt 0.00 -- -- 0.00 50,000 --
Repayment Of Debt -120,000 -84,000 -265,000 -337,000 -2.3M --
Net Issuance Payments Of Debt -120,000 416,000 -265,000 -337,000 -2.2M --
Financing Cash Flow -73,000 447,000 -209,000 -244,000 -2.2M --
Cash Flow From Continuing Financing Activities -73,000 447,000 -209,000 -244,000 -2.2M --
Effect Of Exchange Rate Changes -6,000 38,000 16,000 -47,000 18,000 --
Changes In Cash 228,000 1.9M -3.3M -1.4M -2.9M --
Beginning Cash Position 10.4M 8.4M 11.7M 13.1M 16.0M --
End Cash Position 10.6M 10.4M 8.4M 11.7M 13.1M --
Free Cash Flow -174,000 -2.8M -3.1M -1.1M -695,000 --
Amortization Cash Flow -- -- 45,000 -- -- --
Amortization Of Intangibles -- -- 45,000 -- -- --
Asset Impairment Charge 34,000 165,000 28,000 97,000 -31,000 --
Capital Expenditure Reported -16,000 -42,000 -42,000 -44,000 -33,000 --
Cash Dividends Paid 0.00 0.00 0.00 0.00 0.00 --
Depreciation -- -- 380,000 -- -- --
Gain Loss On Sale Of PPE 147,000 0.00 0.00 0.00 0.00 --
Interest Paid Cff -15,000 -11,000 -14,000 -19,000 -149,000 --
Long Term Debt Issuance -- -- -- 0.00 50,000 --
Long Term Debt Payments -428,000 224,000 -265,000 2.6M -2.3M --
Net Business Purchase And Sale -- -- -- 0.00 0.00 --
Net Foreign Currency Exchange Gain Loss -1,000 22,000 -11,000 -9,000 2,000 --
Net Income From Continuing Operations -2.1M -3.8M -387,000 -1.7M -2.8M --
Net Long Term Debt Issuance 72,000 224,000 -265,000 2.6M -2.2M --
Net Other Financing Charges 62,000 42,000 70,000 98,000 169,000 --
Net Other Investing Changes 440,000 -- -- 0.00 -- 0.00
Operating Gains Losses 146,000 -249,000 -11,000 -9,000 2,000 --
Provisionand Write Offof Assets 5,000 15,000 -7,000 -26,000 0.00 --
Sale Of PPE 35,000 0.00 0.00 0.00 0.00 --
NEWS
Loading news...
TRENDING
Loading...